Flexible evaluation of surrogate markers with Bayesian model averaging
From MaRDI portal
Publication:6630321
DOI10.1002/SIM.9986zbMATH Open1548.62313MaRDI QIDQ6630321
Publication date: 31 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Bayesian model averaging: A tutorial. (with comments and a rejoinder).
- The evaluation of surrogate endpoints.
- Asymptotic behavior of Bayes estimates under possibly incorrect models
- Surrogate measures and consistent surrogates
- Principal Stratification in Causal Inference
- A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
- Evaluating Candidate Principal Surrogate Endpoints
- Related Causal Frameworks for Surrogate Outcomes
- Using a surrogate marker for early testing of a treatment effect
- Comparing biomarkers as trial level general surrogates
- Consistency a Posteriori
- Evaluation of longitudinal surrogate markers
- Evaluating multiple surrogate markers with censored data
- Solutions for Surrogacy Validation with Longitudinal Outcomes for a Gene Therapy
- Robust Approach to Combining Multiple Markers to Improve Surrogacy
- Testing for Heterogeneity in the Utility of a Surrogate Marker
- Optimizing and evaluating biomarker combinations as trial-level general surrogates
- Identifying surrogate markers in real-world comparative effectiveness research
This page was built for publication: Flexible evaluation of surrogate markers with Bayesian model averaging
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6630321)
